1. Introduction {#sec1}
===============

Viral gastroenteritis is a serious viral infection, which affects a large number of individuals all around the world. It constitutes a major threat especially to vulnerable individuals such as children, elderly people, and immunocompromised persons \[[@B15]\]. There are several enteric viruses that can cause gastroenteritis. Epidemiological studies have shown that rotaviruses, astroviruses, enteric adenoviruses (serotypes 40 and 41), and caliciviruses family (*Norovirus* and*Sapovirus*) represent the principal causes of acute gastroenteritis occurring in infants and young children. Enteric human adenoviruses cause acute diarrhea sporadically, as well as in outbreaks, and are considered to be the third leading cause of nonbacterial diarrhea among children.

Human adenoviruses (HAdVs) are classified in the family Adenoviridae, genus*Mastadenovirus*, which contains seven known species, from A to G. Fifty-one serotypes have been classified until now by hemagglutination and serum neutralization reaction, but new adenovirus types, including several emerging and recombinant viruses, have been recently identified based on genomic data. To date there are over 60 types of adenoviruses identified, grouped into seven species. HAdVs are double-stranded, linear DNA viruses displaying genome sizes ranging from 34 to more than 37 kb and carrying 40 genes \[[@B24]\]. The disease spectrum includes, besides gastroenteritis, also respiratory, ocular, and urinary tract infections \[[@B15]\]. Although the clinical course is usually mild and self-limiting, infections may cause outbreaks with severe progression, occasionally leading to a lethal outcome even in immunocompetent individuals. Adenovirus has been associated with persistent infections in both immunocompetent and immunocompromised individuals. These infections have the potential to cause fatal disseminated disease. The disease pattern of adenoviruses infection varies according to virus species. Adenovirus species F, types 40 and 41, has been found to be associated with gastroenteritis and is therefore referred to as enteric adenoviruses. Other species such as A, C, and D have also been associated with diarrhoea.

In Albania, gastroenteritis caused by viral etiologies has not been studied thoroughly and no data are currently available regarding the specific contribution of adenovirus in diarrhoeic disease in children.

The specific objectives of this study were to determine the prevalence of adenovirus infections among children with acute gastroenteritis in Albania and to characterize HAdV strains. Accurate understanding of the relative prevalence of the adenovirus in diarrhoea reported cases could be important information for putting into action effective control and preventive interventions.

2. Materials and Methods {#sec2}
========================

This study was carried out from October 2013 to January 2015. Faecal samples were collected from children hospitalized at the Pediatric University Hospital "Mother Teresa" in Tirana, Albania, with a clinical diagnosis of acute gastroenteritis. At least three evacuations of liquid or semiliquid stools in a 24 h period were required for making a clinical diagnosis of acute gastroenteritis.

During the study period a total of 142 faecal samples were collected (one sample from each hospitalized child), 72 from female and 70 from male children. The average age of the patients was 14 months, ranging from 2 months to 7 years of age. Informed consent was taken from all children\'s parents or legal guardians before filling up the relative questionnaire and taking faecal samples for lab examinations.

Viral nucleic acids were extracted from 10% clarified stool suspensions prepared in phosphate-buffered saline, using the semiautomated platform Nuclisens Easymag (bioMerieux), according to the manufacturer\'s instructions. The extraction process uses magnetic silica-based beads and is based on BOOM technology. Briefly, 400 *μ*L of lysis buffer was added to 200 *μ*L of stool suspension and incubated at room temperature for 10 min. Then 50 *μ*L of magnetic silica particles was added to allow DNA binding. Next, the silica particles were washed twice and wash buffers were removed by vacuum aspiration. Finally, the DNA was recovered from the particles using 100 *μ*L of elution buffer during a 10 min incubation period at 70°C under constant shaking. After the extraction, aliquots of DNA were stored at −80°C and thawed only once.

The collection of faecal samples had been previously investigated for the presence of other enteric viruses (norovirus, sapovirus, enterovirus, rotavirus, and hepatitis A and E viruses) (unpublished data).

Molecular typing assays based on PCR amplification and sequencing of the AdV hexon and fibre genes were used. A portion of the hexon gene was amplified using a nested PCR assay with degenerate primer pair targeting the hypervariable regions HVR1−6 of loop 1, able to amplify all AdV species (universal primers). These primers are able to amplify PCR fragments ranging from 764 to 896 bp in the first PCR, and from 688 to 821 bp in the nested PCR, depending on serotype and species \[[@B17]\]. For amplification of partial fibre gene sequences, published primers based on the conserved regions of this gene were used \[[@B10]\]. The list of primers used in the present study is shown in [Table 1](#tab1){ref-type="table"}. As reference strains for the different HAdV species, we used cultivated clinical strains formerly isolated from hospitalized patients and genetically characterized in a 2006 study \[[@B11]\].

PCR amplification was performed in a 25 *μ*L reaction volume containing 1 *μ*L of each primer (22 pmol *μ*L^−1^) and 2 *μ*L of extracted DNA, using the MyTaq Red Mix Kit (Bioline, UK). A T100 thermal cycler (Bio-Rad) was used with the following settings: denaturation at 94°C for 4 min, followed by 35 cycles of 94°C for 1 min, 45°C for 1 min, and 72°C for 1 min, with a final extension cycle at 72°C for 10 min. After the first round of PCR amplification 1 *μ*L of the volume of the PCR product obtained was used for the second PCR assay using the same conditions. Standard precautions were taken to prevent PCR contamination.

Amplified products were separated on 1* *% agarose gel stained with GelRed. PCR products were purified using a Montage PC* *R*μ*96 Micro-Well Filter Plate (Millipore) and were subjected to automated sequencing (Bio-Fab Research, Rome, Italy).

Bioinformatic analysis was performed as follows: the raw forward and reverse ABI files were aligned and assembled into a single consensus sequence using MEGA software version 6.0. Phylogenetic analysis was performed using the same program.

The nucleotide sequences were compared to reference adenovirus strains available in the GenBank by BLAST, and molecular type identities were assigned based on the identity of the closest match. The phylogenetic tree was constructed based on the best fit model of nucleotide substitution, which was selected from 24 models available in the software, using the minimum Akaike Information Criterion (AIC). The reliability of the phylogenetic tree was determined by bootstrap resampling of 1,000 replicates. The phylogenetic tree based on nucleotide sequences of adenovirus hexon gene obtained in this study is presented in [Figure 1](#fig1){ref-type="fig"}.

3. Results {#sec3}
==========

The degenerate primers targeting the hexon gene were able to amplify HAdV DNA in 33/142 samples (23.2%), yielding amplicons of different lengths, depending on the species present in each sample ([Table 1](#tab1){ref-type="table"}). Positive and negative controls yielded the expected results. Seven different types were identified: HAdV-1 (1 sample), HAdV-2 (8 samples), HAdV-3 (5 samples), HAdV-5 (4 samples), HAdV-12 (1 sample), HAdV-40 (1 sample), and HAdV-41 (13 samples). Species F was the most represented, with 14 positive samples (42.4% of the positive samples), followed by species C (13 positive samples, 39.4%). Species B and A were less represented (15.1% and 3% of positive samples, resp.). Coinfections with rotaviruses were detected in 9/33 (27.2%) samples: 6 species C, 1 species B, and 2 species F.

The phylogenetic tree shown in [Figure 1](#fig1){ref-type="fig"} includes the strains sequenced in this work, along with prototype sequences obtained from GenBank. Low-quality sequences from three samples were not included in the tree. Clinical samples (in bold) formed well-supported monophyletic groups and were represented with their corresponding prototype strains within each species. They were grouped into four main clusters, corresponding to species A, B, C, and F, according to BLAST analysis. Species C was further subdivided into three groups, corresponding to types 1 (1 sample), 2 (8 samples), and 5 (3 samples). Species F was subdivided into two groups corresponding to types 40 (1 sample) and 41 (11 samples).

Positive samples detected with the hexon primers were further analyzed for the fiber gene, using the species-specific primers described in [Section 2](#sec2){ref-type="sec"}. Twenty-one (out of 33) samples were successfully amplified, producing PCR amplicon lengths consistent with expectations. The fiber gene BLAST analysis was concordant with the hexon analysis for these samples.

The data on age, sex, and major clinical symptoms, along with HAdV typing results, are shown in [Table 2](#tab2){ref-type="table"}.

Median age of children positive for HAdV was 13.5 months (4--28 months). Among the 33 infected patients, 17 were male and 12 female. The information on sex was not available for four children. The two main symptoms of gastroenteritis were diarrhea and vomiting. Of the 14 infants and children found positive for HAdV species F, 5 had diarrhea only (one with bloody diarrhea); the others had both diarrhea and vomiting. The remaining 19 patients found positive for species C, B, and A had both diarrhea and vomiting (15 samples) or diarrhea only (4 samples, one with bloody diarrhea). The average duration of symptoms was 3.7 days (range: 1 to 10) and the average number of evacuations per day was 5.2. The longest 10-day duration was associated with the unique species A sample (HAdV-12).

The seasonal distribution of adenovirus gastroenteritis showed a greater prevalence of infection in April and May (13 cases corresponding to 40% of the total number of positive patients).

4. Discussion {#sec4}
=============

Acute gastroenteritis in children, particularly under the age of five, remains a major cause of morbidity and mortality worldwide. In Albania pediatric acute gastroenteritis due to viral etiologies has not been studied thoroughly. The objectives of the present study were to assess the presence of human adenoviruses in pediatric patients with gastroenteritis in hospitalized children and to characterize HAdV strains identified. Samples were tested for HAdV by a PCR assay system targeting the hexon gene. Owing to its hypervariable regions, the hexon region is useful for the classification and recognition of individual serotypes \[[@B7]\]. Indeed, the broad-range primer pair used in this study has been previously found to be capable of amplifying all known HAdVs \[[@B10]\]. Positive samples were subsequently tested using an assay targeting the fiber region. Both the hexon and the fiber genes are considered "hot spots" for base mutations and recombination, which are important driving forces for AdV evolution. Therefore, sequencing the hypervariable regions of the hexon gene and the fiber gene is important for the correct identification and designation of adenovirus strains as demonstrated in previous investigations \[[@B10], [@B9]\]. In the present study, 63% of the positive samples detected in the hexon region were also positive using the fiber assay, and BLAST analysis was concordant with the hexon analysis for these sequences.

The HAdV-positive rate in children with gastrointestinal symptoms was 23.2% (33/142 samples), which is higher than that found in previous similar studies, showing a prevalence ranging from 2% to 19.6% \[[@B2]--[@B5]\]. On the other hand, it should be noted that different and sometimes less sensitive detection methods were used in those studies (including enzyme immunoassay). Moreover, most of the cited papers have addressed exclusively the presence of the "enteric" adenoviruses 40 and 41, while the broad-range assay used in this study is able to detect all known HAdV serotypes. Indeed, a variety of HAdV species (four) and types (seven) were found to circulate among diarrhoeic children in this study. Species F was the most prevalent, followed by species C (mostly HAdV-2). Although species F is frequently found in children with severe gastroenteritis worldwide, nonenteric HAdVs have also been associated with acute gastroenteritis \[[@B12], [@B14]\]. However, the identified HAdV in the sample should not necessarily be considered to be the causative agent of the infection, as infections caused by members of species C and B can result in prolonged shedding in the faeces after a previous infection \[[@B8], [@B1], [@B22]\].

The faecal samples collected for this study had been previously screened for the presence of other enteric viruses. Single HAdV infection was detected in 24/33 cases (72.8%). The only coinfection was found with rotavirus, in 9/33 (27.2% of positive samples). Coinfection adenovirus/rotavirus has been described in other studies on the viral etiology of pediatric gastroenteritis \[[@B2], [@B23], [@B25]\]. A dual infection can be explained by the fact that some viruses from a particular episode continue to be excreted while another virus can cause the acute disease. In any case, the determination of the etiological agent that causes the gastroenteritis can be difficult \[[@B20]\]. In this study 7/9 of the coinfections were associated with nonenteric HAdVs, which can probably support the hypothesis that these adenoviruses are not the causative agent of the infection.

However, we cannot rule out the role of species A/B/C adenoviruses in diarrhea etiology, since 12/19 of nonenteric adenovirus types were detected as unique viral pathogens. Indeed previous reports have described an association of adenoviruses with acute gastroenteritis, particularly HAdV-12, HAdV-18, and HAdV-31 (species A), HAdV-3 and HAdV-7 (species B), and HAdV-1, HAdV-2, and HAdV-5 (species C) \[[@B8]\].

HAdV infection occurred throughout the year, peaking in April and May. This pattern is confirmed by some studies about the seasonality of the virus \[[@B8]\], although other studies have reported no seasonal pattern \[[@B6], [@B27]\].

To the best of our knowledge, only one study on viral gastroenteritis has been published in Albania, addressing the presence of adenoviruses, among other enteric viruses \[[@B4]\]. In that study, published in 2007, enteric adenoviruses were detected in 12.3% of samples, whereas nonenteric adenoviruses were not tested. In the present study, enteric adenoviruses were detected in similar percentages (9.7%); however, nonenteric HAdVs were detected in additional 19 samples (13.4%), 12 of which were unique viral pathogens. These findings highlight the importance of the use of broad-range assays for the detection of all HAdV species, in studies on the viral etiology of gastroenteritis.

In conclusion, the occurrence and molecular characterization of human adenoviruses in pediatric patients with gastroenteritis in Albania are described for the first time in the present study. An accurate understanding of the potential role of HAdV in diarrhea disease is likely to contribute to infection control efforts.
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###### 

Primers used in the present study, targeting the hexon and fiber regions.

  Primer ID   Sequence (5′-3′)             Amplicon size (bp)         Primer position (5′-3′)^*∗*^   Region   Species
  ----------- ---------------------------- -------------------------- ------------------------------ -------- ---------
  1551        TICTTTGACATICGIGGIGTICTIGA   764--896                   19135--19160 (J01917)          Hexon    All
  1553        CTGTCIACIGCCTGRTTCCACA       20051--20030 (J01917)                                              
  1554        GGYCCYAGYTTYAARCCCTAYTC      688--821                   19165--19187 (J01917)                   
  1555        GGTTCTGTCICCCAGAGARTCIAG     20016--19993 (J01917)                                              
                                                                                                              
  1560        TGGAACTTAACAACTGATAT         605                        30400--30419 (NC_001460)       Fiber    A
  1561        ACTTTCATTGTHATRGGT           31004--30987 (NC_001460)                                           
  1545        ATTCCATCGAGTGCACCTACAC       691                        30539--30560 (AY598970)        B        
  1546        GGGTTGACTCCTGTCCATAAGG       31229--31208 (AY598970)                                            
  1708        TTGTTGCAGATGAAACGCGC         433                        31021--31040 (J01917)          C        
  1709        GTTTGGAGTCTTGCACGGT          31453--31435 (J01917)                                              
  1490        AACTGTGCCTTGGAATCATC         499                        29642--29661 (L19443)          F        
  1491        TTAAGGTTAAAGCCCCGTTT                                    30140--30121 (L19443)                   

^*∗*^The primer positions are based on the GenBank sequence accession numbers indicated in parentheses.

###### 

Summary of HAdV-positive patients\' data, including age, date of hospitalization, and main symptoms together with HAdV typing results.

  Patient ID   Age/sex             Date of hospital admission   Main symptoms and clinical course   Coinfection   Serotype
  ------------ ------------------- ---------------------------- ----------------------------------- ------------- ----------
  19           19 months, female   24/12/2013                   Diarrhea and vomit (4 days)         Rotavirus     AdV-2
  22           22 months, female   08/01/2014                   Diarrhea and vomit (1 day)          No            AdV-41
  24           9 months, female    22/01/2014                   Diarrhea and vomit (4 days)         Rotavirus     AdV-5
  25           6 months, male      22/01/2014                   Diarrhea (2 days)                   No            AdV-41
  31           5 months, male      02/02/2014                   Diarrhea and vomit (NA)             No            AdV-3
  33           18 months, NA       02/02/2014                   Diarrhea and vomit (2-3 days)       No            AdV-2
  36           8 months, male      17/02/2014                   Diarrhea (6 days)                   No            AdV-41
  37           18 months, male     17/02/2014                   Diarrhea (2 days )                  No            AdV-41
  39           24 months, male     25/02/2014                   Diarrhea (4 days)                   No            AdV-41
  45           NA                  NA                           NA                                  Rotavirus     AdV-5
  46           12 months, male     02/04/2014                   Diarrhea and vomit (1 day)          No            AdV-41
  47           6 months, male      09/04/2014                   Diarrhea (4 days)                   No            AdV-2
  48           18 months, male     16/04/2014                   Diarrhea (NA)                       Rotavirus     AdV-3
  49           8 months, female    17/04/2014                   Diarrhea and vomit (7 days)         Rotavirus     AdV-40
  50           28 months, male     21/04/2014                   Diarrhea and vomit (5 days)         Rotavirus     AdV-41
  54B          16 months, male     29/04/2014                   Diarrhea and vomit (3 days)         Rotavirus     AdV-2
  58           13 months, female   08/05/2014                   Diarrhea and vomit (2 days)         No            AdV-3
  59           24 months, male     08/05/2014                   Diarrhea with blood (4 days)        No            AdV-41
  64           18 months, female   15/05/2014                   Diarrhea and vomit (2 days)         No            AdV-3
  66           4 months, NA        20/05/2014                   Diarrhea and vomit (4 days)         No            AdV-3
  70           24 months, male     23/05/2014                   Diarrhea and vomit (3-4 days)       No            AdV-41
  72B          6 months, female    28/05/2014                   Diarrhea and vomit (2 days)         Rotavirus     AdV-2
  74           11 months, male     29/05/2014                   Diarrhea and vomit (7 days)         No            AdV-41
  76           11 months, male     05/06/2014                   Diarrhea and vomit (3 days)         No            AdV-41
  80           24 months, male     06/06/2014                   Diarrhea and vomit (3 days)         No            AdV-41
  86           9 months, female    04/07/2014                   Diarrhea and vomit (6 days)         No            AdV-1
  97           8 months, female    06/08/2014                   Diarrhea and vomit (2 days)         No            AdV-41
  99           NA                  NA                           NA                                  No            AdV-5
  100          19 months, male     NA                           Diarrhea and vomit (3 days)         No            AdV-2
  102          6 months, male      25/08/2014                   Diarrhea (3 days)                   No            AdV-2
  103          11 months, female   25/08/2014                   Diarrhea and vomit (10 days)        No            AdV-12
  112          10 months, female   05/09/2014                   Diarrhea with blood (4 days)        No            AdV-5
  134B         5 months, female    26/11/2014                   Diarrhea (5 days)                   Rotavirus     AdV-2

NA = not available.
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